Q2 2014 Sagent Pharmaceuticals Earnings Conference Call (Webcast)

Jul.30.14 | About: Sagent Pharmaceuticals (SGNT)

Sagent Pharmaceuticals (NASDAQ:SGNT): Q2 EPS of $0.09 beats by $0.10. Revenue of $69.2M (+16.1% Y/Y) beats by $2.06M.

The following audio is from a conference call that will begin on July 30, 2014 at 10:00 AM ET. The audio will stream live while the call is active, and can be replayed upon its completion.

If you would like to view a transcript of this call, please click here.